AK-0707

N/A

Report date: 2025/02/27 16:29:36
NME

Base Information

Drug NameAK-0707
Drug Alias NameAK-0707
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionE3 ubiquitin-protein ligase AMFR modulators
TargetsE3 ubiquitin-protein ligase AMFR
Therapy Area/IndicationsIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Ark Biopharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesSuzhou Aikebai Incident Medicine Technology Co LtdShanghai Ark Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsIdiopathic Pulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A